“Development of Nanocrystal Formulations With Improved Dissolution And Bioavailability for BCS Classs-II Drug- Quitapine”. 2022. Journal of Pharmaceutical Negative Results, August, 5113-20. https://doi.org/10.47750/pnr.2022.13.S08.670.